Close
Smartlab Europe
Inizio Ignite
Production & Manufacturing

Sun Pharma gets FDA acceptance for Cranbury manufacturing palnt.

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

BioPharma

Injectable Drug Formulation Trends in Biopharma

Analysis of the evolving landscape of parenteral delivery, focusing on the stability of high-concentration biologics and the integration of patient-centric delivery devices.
Drug Research

Advancing Drug Formulation Stability in Modern Pharma

Exploration of the chemical, physical, and environmental factors that compromise the integrity of modern therapeutics, and the advanced testing protocols used to ensure safety.
Drug Research

Lipid-Based Drug Delivery System for Low-Soluble Drugs

Detailed review of how lipidic excipients and nano-emulsified systems are utilized to enhance the absorption and bioavailability of hydrophobic pharmaceutical compounds.
- Advertisement -

Sun Pharmaceutical has received the US Food and Drug Administration (FDA) acceptance for its manufacturing plant at Cranbury in New Jersey, US.

Earlier, the company has received a warning letter from the agency on 25 August 2010 for violating good manufacturing practice regulations. The issuance of the letter follows FDA inspection of the site.

Caraco, now wholly owned by Sun Pharma, continues to work with consultants to resolve the issues raised by the FDA at its Detroit plant.

Latest stories

Previous article
MHRA approves Ajanta Pharma Paithan manufacturing plant
Next article
CMC Biologics, Inspiration team up to manufacture hemophilia B drug

Related stories

BioPharma

Injectable Drug Formulation Trends in Biopharma

Analysis of the evolving landscape of parenteral delivery, focusing on the stability of high-concentration biologics and the integration of patient-centric delivery devices.
Drug Research

Advancing Drug Formulation Stability in Modern Pharma

Exploration of the chemical, physical, and environmental factors that compromise the integrity of modern therapeutics, and the advanced testing protocols used to ensure safety.
Drug Research

Lipid-Based Drug Delivery System for Low-Soluble Drugs

Detailed review of how lipidic excipients and nano-emulsified systems are utilized to enhance the absorption and bioavailability of hydrophobic pharmaceutical compounds.
Drug Research

Formulation Strategies for Improving Drug Bioavailability

Analysis of the chemical and physical methodologies employed to overcome solubility and permeability barriers, ensuring active pharmaceutical ingredients reach systemic circulation effectively.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

About us

World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives. . . Read More

SUBSCRIBE US

System

RESOURCES

ARCHIVE LINKS

Subscribe

Copyright © 2010-2026 World Pharma Today. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »
MORE STORIES
injectable drug formulation trends

Injectable Drug Formulation Trends in Biopharma

ACG Packaging Materials

ACG Packaging Materials Joins WEF Global Lighthouse Network